BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26171980)

  • 1. Serum proteomic profiling of major depressive disorder.
    Bot M; Chan MK; Jansen R; Lamers F; Vogelzangs N; Steiner J; Leweke FM; Rothermundt M; Cooper J; Bahn S; Penninx BW
    Transl Psychiatry; 2015 Jul; 5(7):e599. PubMed ID: 26171980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
    Stelzhammer V; Haenisch F; Chan MK; Cooper JD; Steiner J; Steeb H; Martins-de-Souza D; Rahmoune H; Guest PC; Bahn S
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1599-608. PubMed ID: 24901538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered anatomical patterns of depression in relation to antidepressant treatment: Evidence from a pattern recognition analysis on the topological organization of brain networks.
    Qin J; Wei M; Liu H; Chen J; Yan R; Yao Z; Lu Q
    J Affect Disord; 2015 Jul; 180():129-37. PubMed ID: 25898333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients.
    Kim EY; Lee JW; Lee MY; Kim SH; Mok HJ; Ha K; Ahn YM; Kim KP
    Psychiatry Res; 2018 Jul; 265():174-182. PubMed ID: 29719272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands Study of Depression and Anxiety.
    Gibson-Smith D; Bot M; Milaneschi Y; Twisk JW; Visser M; Brouwer IA; Penninx BW
    J Clin Psychiatry; 2016 Feb; 77(2):e144-51. PubMed ID: 26760137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
    Ramsey JM; Cooper JD; Bot M; Guest PC; Lamers F; Weickert CS; Penninx BW; Bahn S
    PLoS One; 2016; 11(5):e0156624. PubMed ID: 27232630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying current and remitted major depressive disorder with the Hurst exponent: a comparative study on two automated anatomical labeling atlases.
    Jing B; Long Z; Liu H; Yan H; Dong J; Mo X; Li D; Liu C; Li H
    Oncotarget; 2017 Oct; 8(52):90452-90464. PubMed ID: 29163844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-based morphometry study of the insular cortex in female patients with current and remitted depression.
    Liu CH; Jing B; Ma X; Xu PF; Zhang Y; Li F; Wang YP; Tang LR; Wang YJ; Li HY; Wang CY
    Neuroscience; 2014 Mar; 262():190-9. PubMed ID: 24406440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.
    Çakici N; Bot M; Lamers F; Janssen T; van der Spek PJ; de Haan L; Bahn S; Penninx BWJH; van Beveren NJM
    Eur Neuropsychopharmacol; 2019 Jul; 29(7):835-846. PubMed ID: 31230885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder.
    Gottschalk MG; Cooper JD; Chan MK; Bot M; Penninx BW; Bahn S
    Brain Behav Immun; 2015 Aug; 48():123-31. PubMed ID: 25929723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
    Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
    Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the serum N-glycan profile in female patients with Major Depressive Disorder.
    Boeck C; Pfister S; Bürkle A; Vanhooren V; Libert C; Salinas-Manrique J; Dietrich DE; Kolassa IT; Karabatsiakis A
    J Affect Disord; 2018 Jul; 234():139-147. PubMed ID: 29529546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).
    van Reedt Dortland AK; Giltay EJ; van Veen T; van Pelt J; Zitman FG; Penninx BW
    J Clin Psychiatry; 2010 Jun; 71(6):729-36. PubMed ID: 20021996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls.
    Lorenzetti V; Allen NB; Whittle S; Yücel M
    J Affect Disord; 2010 Jan; 120(1-3):112-9. PubMed ID: 19464062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of depression heterogeneity using proteomic clusters.
    van Haeringen M; Milaneschi Y; Lamers F; Penninx BWJH; Jansen R
    Psychol Med; 2023 May; 53(7):2904-2912. PubMed ID: 35039097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in major depressive disorder: the role of mass spectrometry.
    Woods AG; Iosifescu DV; Darie CC
    Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk.
    Wiener CD; de Mello Ferreira S; Pedrotti Moreira F; Bittencourt G; de Oliveira JF; Lopez Molina M; Jansen K; de Mattos Souza LD; Rizzato Lara D; Portela LV; da Silva RA; Oses JP
    J Affect Disord; 2015 Sep; 184():245-8. PubMed ID: 26118751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.